DiscoveryX
DiscoveryX is a modular analytics toolbox for genetics-led drug discovery, designed to enable pharmaceutical and biotech teams to build and scale their own internal analytics platforms. It integrates publicly available and proprietary datasets within a governed, reproducible framework, supporting the systematic analysis of large-scale genomic and clinical data. By combining advanced multi-trait colocalisation, multi-omics integration and knowledge graph generation across thousands of traits, DiscoveryX transforms genetic association data into structured, decision-ready biological insight, enabling more informed target discovery and reducing translational risk.
Here’s what’s included in the platform:
PleioGraph
PleioGraph is a suite of ML algorithms designed to empower pharmaceutical, biopharmaceutical, and biotech companies in identifying candidate causal genes, proteins, or drug targets for novel therapeutics. With a focus on delivering precise insights driven by algorithms, PleioGraph meets the demands of advanced research, enabling the efficient processing of extensive datasets.
PleioGraph
PleioGraph offers practical benefits for clients in pharmaceutical, biopharmaceutical, and biotech sectors. It accelerates data analysis, saving time and resources while identifying candidate genes, proteins, and drug targets. It provides clear visibility of genetic signals, including where they occur, their direction, and frequency, alongside key regional context. Visualisations help teams understand relationships between traits and identify shared or opposing patterns, improving insight into disease mechanisms and reducing the risk of false leads and costly errors.
PleioGraph: SwitchStep
SwitchStep is an innovative methodology in drug discovery that utilizes human genetics to accelerate the identification of potential drug targets. By analyzing genetic data, SwitchStep efficiently pinpoints risk genes associated with diseases, minimizing the need for extensive laboratory testing. This precision not only reduces the cost, time, and labor traditionally required in the drug discovery process but also considerably enhances the success rate of clinical trials.
PleioGraph: SwitchStep
Unlike slower fine-mapping techniques, SwitchStep is designed for scalability, allowing it to be applied across thousands of genetic regions and traits, making it ideal for industrial settings. SwitchStep offers a practical solution for quickly identifying promising genetic variants linked to specific phenotypes, streamlining the development of safer and more effective drugs.
PleioGraph: ImpMap
Understanding human genetics is crucial for drug discovery, as it reveals disease causes and improves clinical trial success rates. However, integrating genetic data often results in gaps that require imputation. To overcome these challenges, we’ve developed ImpMap. This innovative solution not only simplifies genetic imputation but also offers significant advantages. ImpMap transforms genetic analysis, reducing processing times, enhancing accuracy, and enabling thorough exploration of potential drug targets, thereby advancing the drug discovery process.
PleioGraph: ImpMap
ImpMap’s scalability allows suitability for large-scale analyses with extensive datasets. Its capability to handle complex genetic data effortlessly allows researchers to conduct comprehensive studies and explore diverse potential drug targets. This scalability empowers researchers to make informed decisions and advance drug development efforts confidently, knowing they have access to accurate and efficient genetic analysis tools.
Cloud CEO
Cloud CEO gives organisations clear visibility of cloud cost drivers across complex data environments, enabling faster, more confident cost reduction. It identifies inefficient query behaviours and surfaces anti-patterns that drive unnecessary spend across teams and workloads. By quantifying cost impact and prioritising optimisation opportunities, it focuses action where it will deliver the greatest savings. Ongoing monitoring of workloads and emerging cost drivers ensures sustained control, supporting continuous optimisation and measurable reduction in cloud spend.
Try and test bioXcelerate products firsthand and discover tomorrow’s drug today.
